Clinical Advances in Gastric Cancer
Pertuzumab Plus Trastuzumab Promising In HER2-Positive Biliary-Tract Cancers
December 1, 2021
Dual anti-HER2 treatment with pertuzumab plus trastuzumab appears well tolerated and gives promising results in certain patients with HER2-positive advanced cancer of the biliary tract...
FDA Grants Fast Track Designation to FGFR Inhibitor for Cholangiocarcinoma Treatment
December 9, 2021The FDA granted fast track designation to TT-00420, a FGFR spectrum selective kinase inhibitor, for the potential treatment of patients with cholangiocarcinoma with no standard treatment options...
Staging Laparoscopy, But Not PET, Beneficial in Locally Advanced Gastric Cancer
November 29, 2021For staging patients with locally advanced gastric cancer, laparoscopy is likely beneficial, but DG-PET/CT (18F-fludeoxyglucose-positron emission tomography with computed tomography) is not...
Add-On Ramucirumab Increases PFS, Not Overall Survival, in East Asians with Advanced Gastric Cancer
November 23, 2021Adding ramucirumab to paclitaxel as second-line therapy for advanced gastric cancer boosts progression-free survival (PFS) in East Asian patients...
Perioperative SOX Protocol Bests Adjuvant CapOx in Locally Advanced Gastric Cancer
November 11, 2021In patients who had a D2 gastrectomy, perioperative administration of the oral fluoropyrimidine derivative S-1 and oxaliplatin (SOX) yielded better outcomes than adjuvant capecitabine and oxaliplatin (CapOx)...
AI Improves Detection of Gastric Neoplasms During Routine Endoscopies
September 29, 2021The use of an artificial intelligence (AI) system during upper gastrointestinal (GI) endoscopies significantly cut the number of missed gastric neoplasms compared with conventional endoscopy not powered by AI...
